Anders Karlsson

3.5k total citations · 1 hit paper
58 papers, 2.8k citations indexed

About

Anders Karlsson is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anders Karlsson has authored 58 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Virology, 16 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Anders Karlsson's work include HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (12 papers) and Immune Cell Function and Interaction (8 papers). Anders Karlsson is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (12 papers) and Immune Cell Function and Interaction (8 papers). Anders Karlsson collaborates with scholars based in Sweden, United States and United Kingdom. Anders Karlsson's co-authors include Jan Albert, Gunnel Biberfeld, Linda Morfeldt-Månson, Eva-Maria Fenyö, Birgitta Åsjö, Knut Lidman, Bonaventura Clotet, Marianne Jansson, Michael W. Dunne and Nathan Clumeck and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Anders Karlsson

56 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

2008 570 citations Roy M. Gulick, Jacob Lalezari et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Karlsson Sweden	27	1.6k	1.2k	699	611	271	58	2.8k
Jean‐Paul Viard France	30	1.8k 1.1×	1.8k 1.4×	671 1.0×	713 1.2×	152 0.6×	98	3.4k
Arye Rubinstein United States	34	1.3k 0.8×	1.5k 1.2×	1.1k 1.6×	1.4k 2.3×	239 0.9×	115	3.7k
Ian Williams United Kingdom	33	1.5k 0.9×	1.5k 1.2×	781 1.1×	808 1.3×	222 0.8×	102	3.2k
E. McKinnon Australia	25	1.1k 0.7×	1.3k 1.1×	505 0.7×	717 1.2×	196 0.7×	90	2.9k
Israel Yust Israel	21	770 0.5×	1.1k 0.9×	361 0.5×	642 1.1×	186 0.7×	81	2.5k
P T Schellekens Netherlands	23	1.8k 1.1×	1.2k 1.0×	1.1k 1.6×	683 1.1×	193 0.7×	52	2.7k
JoAnn M. Mican United States	29	2.6k 1.6×	1.9k 1.5×	1.6k 2.2×	807 1.3×	389 1.4×	48	4.1k
Giuseppe Tambussi Italy	42	2.7k 1.7×	1.9k 1.5×	2.7k 3.9×	1.0k 1.7×	351 1.3×	149	5.3k
Robin Mogg United States	16	853 0.5×	596 0.5×	795 1.1×	556 0.9×	526 1.9×	44	2.7k
Edward D. Gomperts United States	32	1.9k 1.2×	1.3k 1.0×	1.3k 1.9×	740 1.2×	746 2.8×	137	5.2k

Countries citing papers authored by Anders Karlsson

Since Specialization

Citations

This map shows the geographic impact of Anders Karlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Karlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Karlsson more than expected).

Fields of papers citing papers by Anders Karlsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Karlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Karlsson. The network helps show where Anders Karlsson may publish in the future.

Co-authorship network of co-authors of Anders Karlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Karlsson. A scholar is included among the top collaborators of Anders Karlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Karlsson. Anders Karlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Landin‐Wilhelmsen, Kerstin, Kerstin Berntorp, Inger Bryman, et al.. (2024). Psychiatric disorders and comorbidity in women with Turner Syndrome: a retrospective national cohort study. Translational Psychiatry. 14(1). 355–355. 1 indexed citations

Naessén, Sabine, Kerstin Berntorp, Penelope Trimpou, et al.. (2023). Autoimmune Disease in Turner Syndrome in Sweden: An up to 25 Years’ Controlled Follow-up Study. The Journal of Clinical Endocrinology & Metabolism. 109(2). e602–e612. 4 indexed citations

Karlsson, Anders, et al.. (2019). The accuracy of incremental pre-operative breast MRI findings – Concordance with histopathology in the Swedish randomized multicenter POMB trial. European Journal of Radiology. 114. 185–191. 8 indexed citations

Karlsson, Anders. (2013). Role of mast cells and probiotics in the regulation of intestinal barrier function. Linköping University Electronic Press eBooks. 1 indexed citations

Karlsson, Anders, et al.. (2013). Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 5(1). 15–15. 21 indexed citations

Reekie, Joanne, Justyna Kowalska, Igor Karpov, et al.. (2012). Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study. PLoS ONE. 7(7). e41673–e41673. 35 indexed citations

Repits, Johanna, Jasminka Sterjovski, Hannes Uchtenhagen, et al.. (2011). Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge. PLoS ONE. 6(6). e20135–e20135. 27 indexed citations

Sundström, Anders, Börje Åkerlund, Anders Karlsson, et al.. (2010). Increased risk of abdominal wall hernia associated with combination anti‐retroviral therapy in HIV‐infected patients—results from a Swedish cohort‐study. Pharmacoepidemiology and Drug Safety. 19(5). 465–473. 3 indexed citations

Repits, Johanna, Jasminka Sterjovski, Melissa J. Churchill, et al.. (2008). Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression. Retrovirology. 5(1). 28–28. 21 indexed citations

10.

Soriano, Vincent, Amanda Mocroft, Bruno Ledergerber, et al.. (2008). Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe. The Journal of Infectious Diseases. 198(9). 1337–1344. 131 indexed citations

11.

Repits, Johanna, Jasminka Sterjovski, Mattias Mild, et al.. (2008). Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge. Virology. 379(1). 125–134. 36 indexed citations

12.

Gulick, Roy M., Jacob Lalezari, James Goodrich, et al.. (2008). Maraviroc for Previously Treated Patients with R5 HIV-1 Infection. New England Journal of Medicine. 359(14). 1429–1441. 570 indexed citations breakdown →

13.

Réthi, Bence, Phạm Hồng Thắng, Nancy Vivar, et al.. (2007). Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control. AIDS. 21(8). 1048–1050. 13 indexed citations

14.

Casper, Charlotte, Mattias Mild, Marianne Jansson, et al.. (2005). Coreceptor Usage of Primary HIV Type 1 Isolates Obtained from Different Lymph Node Subsets. AIDS Research and Human Retroviruses. 21(12). 1003–1010.

15.

Ekman, Robert, et al.. (1999). Bicycle injuries in Western Sweden: a comparison between counties. Accident Analysis & Prevention. 31(1-2). 13–19. 13 indexed citations

16.

Karlsson, Anders, Göran Bratt, Geo von Krogh, et al.. (1991). A prospective study of 115 initially asymptomatic HIV infected gay men in stockholm, sweden. Scandinavian Journal of Infectious Diseases. 23(4). 431–441. 11 indexed citations

17.

Fagius, Jan, Kerstin Westermark, & Anders Karlsson. (1990). BAROREFLEX‐GOVERNED SYMPATHETIC OUTFLOW TO MUSCLE VASCULATURE IS INCREASED IN HYPOTHYROIDISM. Clinical Endocrinology. 33(2). 177–186. 19 indexed citations

18.

Böttiger, Blenda, et al.. (1989). Cross-Neutralizing Antibodies Against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a New Isolate SBL-K135). AIDS Research and Human Retroviruses. 5(5). 525–533. 15 indexed citations

19.

Putkonen, Per, et al.. (1988). Group Specific Component and Susceptibility to HIV Infection and Progression to AIDS. Scandinavian Journal of Infectious Diseases. 20(1). 11–14. 2 indexed citations

20.

Jansson, Rolf, Per Anders Dahlberg, Brita Winsa, et al.. (1987). The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women. European Journal of Endocrinology. 116(3). 321–325. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact